Clinical Trial Update: Comparison of the Antiplatelet Efficacy of Aspirin Combined With Clopidogrel and Aspirin Combined With Half-dose Ticagrelor in Patients With Unruptured Intracranial Aneurysms With Normal CYP2C19 Metabolizer Phenotype [Phase 4]

View source ↗

Summary

This Phase 4 trial compares the antiplatelet efficacy of aspirin plus clopidogrel versus aspirin plus half-dose ticagrelor in patients with unruptured intracran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Intracranial Aneurysms, Antiplatelet Drugs | Phase 4 | Status: NOT_YET_RECRUITING